Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and Safety of the Intratracheal Administration of Budesonide With Porcine Pulmonary Surfactant in Very Preterm Infants to Prevent Bronchopulmonary Dysplasia: Randomized Clinical Trial (BuS Trial)

Next Previous
X
Search
Trial Profile

Efficacy and Safety of the Intratracheal Administration of Budesonide With Porcine Pulmonary Surfactant in Very Preterm Infants to Prevent Bronchopulmonary Dysplasia: Randomized Clinical Trial (BuS Trial)

Status: Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Poractant alfa (Primary) ; Budesonide
  • Indications Bronchopulmonary dysplasia; Neonatal respiratory distress syndrome
  • Focus Biomarker; Therapeutic Use
  • Acronyms BuS

    • Most Recent Events

    • 06 Sep 2021 Planned End Date changed from 15 Nov 2025 to 1 Apr 2026.
    • 06 Sep 2021 Planned primary completion date changed from 15 Nov 2023 to 1 Apr 2024.
    • 06 Sep 2021 Planned initiation date changed from 15 May 2021 to 1 Oct 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top